Question 1

What is the catalog number for Compound NP-019554?

Accepted Answer

The catalog number for Compound NP-019554 is T129101.

Question 2

Is Compound NP-019554 in stock?

Accepted Answer

Compound NP-019554 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound NP-019554?

Accepted Answer

Compound NP-019554 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound NP-019554?

Accepted Answer

Estimated delivery time for Compound NP-019554 is approximately 10 business day(s), depending on your location.

Question 5

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 6

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 7

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Compound NP-019554

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

(E, E) -11,13-Hexadecadien-1-ol

1-[4- (Difluoromethyl) -6- (1-ethyl-5-methyl-1H-pyrazol-4-yl) pyrimidin-2-yl]piperidin-4-amine

1-[4- (Difluoromethyl) -6- (1-ethyl-5-methyl-1H-pyrazol-4-yl) pyrimidin-2-yl]piperidin-4-amine

C-fos Polyclonal Antibody, APC-Cy5.5 Conjugated

REG4 Blocking Peptide

REG4 Blocking Peptide